Skip to main content
OpenTrials
Completed

NCT Number: NCT00926939

Technological Innovations in Behavioral Treatments for Cigarette Smoking

The purpose of the study is to evaluate a sustainable and broadly accessible treatment delivery model (Motiv8) for smoking cessation based on abstinence-reinforcement.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

National Development and Research Institutes

New York, 10010, United States

About this study

Smokers are randomly assigned to one of two groups: an Abstinence Contingent (AC) group and a Submission Contingent (SC) group. The AC group receives vouchers for abstaining from smoking (measured by a carbon monoxide monitor and confirmed through video-submission), and the SC group receives vouchers for submitting videos of their carbon monoxide breath tests. Both groups take videos of their CO-monitoring on a secure website designed for the study, as well as receive standard care counseling and education related to smoking cessation. The main intervention lasts four weeks, and a three-week maintenance phase will follow. Assessments will be conducted at intake, week four (end of the main treatment phase), and at three and six months after the intervention period is completed

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Self-reported smoker
  • Permission to contact applicant by phone
  • Ability to use the internet

Exclusion criteria

  • Self-report of a history of or current severe or unstable medical or psychiatric illness that would interfere with the study

Treatment and study plan

Reinforcement for the abstinence of smoking

Behavioral

Participants in this intervention group will receive vouchers contingent upon a CO sample of 4ppm or less.

Reinforcement for submission of videos with CO sample

Behavioral

This intervention group will receive vouchers contingent on their submission of videos of their CO breath tests.

Primary outcomes

  1. CO sample of ≤ 4ppm

    Time frame: 4 weeks, 7 weeks during intervention; 3 months and 6 months after intervention

  2. Participant reporting not smoking, not even a puff in the last 7 days.

    Time frame: 4 weeks, 7 weeks during intervention; 3 months and 6 months after intervention

Secondary outcomes

  1. Twice-daily breath CO samples obtained during treatment period.

    Time frame: First 4 weeks of treatment

  2. The longest duration of sustained abstinence based on the twice-daily breath samples during the treatment period.

    Time frame: First 4 weeks of treatment

Sponsors and collaborators

Lead sponsor

National Development and Research Institutes, Inc.

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Important dates

Study start
2009
Primary completion
2014
Study completion
2014
First posted
Jun 24, 2009
Registry last updated
Apr 14, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.